CYFRA 21-1 predicts the efficacy of nivolumab in patients with advanced lung adenocarcinoma

CYFRA 21-1 predicts the efficacy of nivolumab in patients with advanced lung adenocarcinoma

CYFRA 21-1 is a prognostic marker for non–small cell lung cancer. The serum CYFRA 21-1 level is also known as an adjunct for the diagnosis of lung squamous cell carcinoma. This study aimed to examine whether CYFRA 21-1 has predictive implications for nivolumab therapy in patients with advanced lung...

Full description

Bibliographic Details
Main Authors: Hiromichi Shirasu, Akira Ono, Katsuhiro Omae, Kazuhisa Nakashima, Shota Omori, Kazushige Wakuda, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Masahiro Endo, Takashi Nakajima, Toshiaki Takahashi
Format: Article
Language:English
Published: IOS Press 2018-02-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428318760420

Internet

https://doi.org/10.1177/1010428318760420

Similar Items